$599

AZ Obesity Investor Event; Novo on 60 Minutes; Vertex Advances T1DM Cell Therapy; One Health CGM startup; New GLP-1RA Label Updates

A series of cardiometabolic-related news items have been observed from: AstraZeneca, Novo Nordisk, Vertex, and One Health Biosensing. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here